212 related articles for article (PubMed ID: 24530123)
1. Improved liver function and relieved pruritus after 4-phenylbutyrate therapy in a patient with progressive familial intrahepatic cholestasis type 2.
Naoi S; Hayashi H; Inoue T; Tanikawa K; Igarashi K; Nagasaka H; Kage M; Takikawa H; Sugiyama Y; Inui A; Nagai T; Kusuhara H
J Pediatr; 2014 May; 164(5):1219-1227.e3. PubMed ID: 24530123
[TBL] [Abstract][Full Text] [Related]
2. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
[TBL] [Abstract][Full Text] [Related]
3. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
[TBL] [Abstract][Full Text] [Related]
4. Intractable itch relieved by 4-phenylbutyrate therapy in patients with progressive familial intrahepatic cholestasis type 1.
Hasegawa Y; Hayashi H; Naoi S; Kondou H; Bessho K; Igarashi K; Hanada K; Nakao K; Kimura T; Konishi A; Nagasaka H; Miyoshi Y; Ozono K; Kusuhara H
Orphanet J Rare Dis; 2014 Jul; 9():89. PubMed ID: 25022842
[TBL] [Abstract][Full Text] [Related]
5. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
Hayashi H; Sugiyama Y
Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
[TBL] [Abstract][Full Text] [Related]
6. Short-chain ubiquitination is associated with the degradation rate of a cell-surface-resident bile salt export pump (BSEP/ABCB11).
Hayashi H; Sugiyama Y
Mol Pharmacol; 2009 Jan; 75(1):143-50. PubMed ID: 18829893
[TBL] [Abstract][Full Text] [Related]
7. A Drug Regimen for Progressive Familial Cholestasis Type 2.
Malatack JJ; Doyle D
Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29284646
[TBL] [Abstract][Full Text] [Related]
8. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
[TBL] [Abstract][Full Text] [Related]
9. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
[TBL] [Abstract][Full Text] [Related]
10. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma.
Scheimann AO; Strautnieks SS; Knisely AS; Byrne JA; Thompson RJ; Finegold MJ
J Pediatr; 2007 May; 150(5):556-9. PubMed ID: 17452236
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
12. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
[TBL] [Abstract][Full Text] [Related]
13. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2.
Maggiore G; Gonzales E; Sciveres M; Redon MJ; Grosse B; Stieger B; Davit-Spraul A; Fabre M; Jacquemin E
J Hepatol; 2010 Nov; 53(5):981-6. PubMed ID: 20800306
[TBL] [Abstract][Full Text] [Related]
14. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
15. BSEP: function and role in progressive familial intrahepatic cholestasis.
Thompson R; Strautnieks S
Semin Liver Dis; 2001 Nov; 21(4):545-50. PubMed ID: 11745042
[TBL] [Abstract][Full Text] [Related]
16. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
Keitel V; Vogt C; Häussinger D; Kubitz R
Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
[TBL] [Abstract][Full Text] [Related]
17. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.
Wang L; Soroka CJ; Boyer JL
J Clin Invest; 2002 Oct; 110(7):965-72. PubMed ID: 12370274
[TBL] [Abstract][Full Text] [Related]
18. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
[TBL] [Abstract][Full Text] [Related]
19. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.
Harmancı Ö; Ensaroğlu F; Özçay F; Öcal S; Korkmaz M; Özdemir BH; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():107-9. PubMed ID: 26640927
[TBL] [Abstract][Full Text] [Related]
20. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
Lam P; Pearson CL; Soroka CJ; Xu S; Mennone A; Boyer JL
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]